Free Trial

Scancell (SCLP) Competitors

Scancell logo
GBX 11 0.00 (0.00%)
(As of 12/20/2024 12:06 PM ET)

SCLP vs. HZD, VRP, ARIX, BVXP, FARN, AVCT, 4BB, CIR, HVO, and TILS

Should you be buying Scancell stock or one of its competitors? The main competitors of Scancell include Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Bioventix (BVXP), Faron Pharmaceuticals Oy (FARN), Avacta Group (AVCT), 4basebio (4BB), Circassia Group (CIR), hVIVO (HVO), and Tiziana Life Sciences (TILS). These companies are all part of the "biotechnology" industry.

Scancell vs.

Horizon Discovery Group plc (HZD.L) (LON:HZD) and Scancell (LON:SCLP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership, community ranking and earnings.

Horizon Discovery Group plc (HZD.L) has higher revenue and earnings than Scancell. Scancell is trading at a lower price-to-earnings ratio than Horizon Discovery Group plc (HZD.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Horizon Discovery Group plc (HZD.L)£54.63M0.00N/A-£5.50N/A
Scancell£5.27M19.40-£5.86M-£0.01-1,100.00

Horizon Discovery Group plc (HZD.L)'s return on equity of 0.00% beat Scancell's return on equity.

Company Net Margins Return on Equity Return on Assets
Horizon Discovery Group plc (HZD.L)N/A N/A N/A
Scancell N/A -269.84%-45.28%

46.5% of Scancell shares are owned by institutional investors. 5.0% of Scancell shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Horizon Discovery Group plc (HZD.L) received 274 more outperform votes than Scancell when rated by MarketBeat users. However, 74.50% of users gave Scancell an outperform vote while only 73.52% of users gave Horizon Discovery Group plc (HZD.L) an outperform vote.

CompanyUnderperformOutperform
Horizon Discovery Group plc (HZD.L)Outperform Votes
461
73.52%
Underperform Votes
166
26.48%
ScancellOutperform Votes
187
74.50%
Underperform Votes
64
25.50%

In the previous week, Horizon Discovery Group plc (HZD.L)'s average media sentiment score of 0.00 equaled Scancell'saverage media sentiment score.

Company Overall Sentiment
Horizon Discovery Group plc (HZD.L) Neutral
Scancell Neutral

Summary

Horizon Discovery Group plc (HZD.L) beats Scancell on 5 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCLP vs. The Competition

MetricScancellBiotechnology IndustryMedical SectorLON Exchange
Market Cap£102.26M£164.65M£5.14B£1.88B
Dividend YieldN/A3.64%5.09%5.54%
P/E Ratio-1,100.00115.5190.051,810.29
Price / Sales19.4018,239.951,117.14382,807.21
Price / Cash7.8612.7543.0428.42
Price / BookN/A8.504.782.91
Net Income-£5.86M-£20.67M£120.31M£156.83M
7 Day Performance2.33%-1.04%-1.92%-1.92%
1 Month Performance-22.04%136.65%11.51%17.93%
1 Year PerformanceN/A137.57%30.61%29.50%

Scancell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCLP
Scancell
N/AGBX 11
flat
N/A+0.1%£102.26M£5.27M-1,100.0051
HZD
Horizon Discovery Group plc (HZD.L)
N/AGBX 184.50
flat
N/A+0.0%£302.98M£54.63M-33.55416
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/A+0.0%£228MN/A-1.6822News Coverage
Gap Up
ARIX
Arix Bioscience
N/AN/AN/A+17.4%£183.73M£14.16M1,290.919
BVXP
Bioventix
N/AGBX 3,480.21
+0.7%
N/A-24.1%£181.67M£13.60M2,135.1012
FARN
Faron Pharmaceuticals Oy
N/AN/AN/A-44.0%£175.45M£-725,000.00-524.0634
AVCT
Avacta Group
N/AGBX 45.75
+6.4%
N/A-58.2%£163.92M£22.62M-513.33120News Coverage
Negative News
4BB
4basebio
N/AGBX 1,210
+2.1%
N/A+83.3%£155.00M£311,000.00-1,519.23101Positive News
CIR
Circassia Group
N/AN/AN/A+0.0%£142.66M£27.90M3,400.00111News Coverage
Gap Down
HVO
hVIVO
N/AGBX 20.75
-3.5%
N/A-11.7%£141.18M£67.21M723.33N/ANews Coverage
TILS
Tiziana Life Sciences
N/AGBX 58.50
+8.3%
N/A+0.0%£113.85M£-3,595,000.00-3.5911

Related Companies and Tools


This page (LON:SCLP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners